207 related articles for article (PubMed ID: 14609432)
1. Ovarian surface epithelium: family history and early events in ovarian cancer.
Wong AS; Auersperg N
Reprod Biol Endocrinol; 2003 Oct; 1():70. PubMed ID: 14609432
[TBL] [Abstract][Full Text] [Related]
2. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
3. [Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme].
Chene G; Dauplat J; Raoelfils I; Bignon YJ; Cayre A; Jaffeux P; Aublet-Cuvelier B; Pomel C; Penault-Llorca F
Ann Pathol; 2011 Feb; 31(1):3-10. PubMed ID: 21349382
[TBL] [Abstract][Full Text] [Related]
4. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
6. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
7. Activation of BTAK expression in primary ovarian surface epithelial cells of prophylactic ovaries.
Zhang Z; Singh M; Davidson S; Rosen DG; Yang G; Liu J
Mod Pathol; 2007 Oct; 20(10):1078-84. PubMed ID: 17673924
[TBL] [Abstract][Full Text] [Related]
8. Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes.
Cortesi L; Turchetti D; Bertoni C; Zanocco-Marani T; Vinceti M; Silvestri C; Federico M; Silingardi V; Ferrari S
Eur J Hum Genet; 2003 Mar; 11(3):210-4. PubMed ID: 12673274
[TBL] [Abstract][Full Text] [Related]
9. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
10. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.
Weber F; Shen L; Fukino K; Patocs A; Mutter GL; Caldes T; Eng C
Am J Hum Genet; 2006 Jun; 78(6):961-72. PubMed ID: 16685647
[TBL] [Abstract][Full Text] [Related]
11. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
12. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma.
Kim YT; Nam EJ; Yoon BS; Kim SW; Kim SH; Kim JH; Kim HK; Koo JS; Kim JW
Gynecol Oncol; 2005 Dec; 99(3):585-90. PubMed ID: 16084575
[TBL] [Abstract][Full Text] [Related]
15. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
16. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.
Zhang L; Wang D; Jiang W; Edwards D; Qiu W; Barroilhet LM; Rho JH; Jin L; Seethappan V; Vitonis A; Wang J; Mok SC; Crum C; Cramer DW; Ye B
Reprod Biol Endocrinol; 2010 Jun; 8():74. PubMed ID: 20576130
[TBL] [Abstract][Full Text] [Related]
17. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium.
Wong AS; Kim SO; Leung PC; Auersperg N; Pelech SL
Gynecol Oncol; 2001 Aug; 82(2):305-11. PubMed ID: 11531284
[TBL] [Abstract][Full Text] [Related]
18. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
He QY; Zhou Y; Wong E; Ehlen TG; Auersperg N; Chiu JF; Wong AS
Gynecol Oncol; 2005 Jul; 98(1):68-76. PubMed ID: 15913737
[TBL] [Abstract][Full Text] [Related]
20. Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer.
Dyck HG; Hamilton TC; Godwin AK; Lynch HT; Maines-Bandiera S; Auersperg N
Int J Cancer; 1996 Dec; 69(6):429-36. PubMed ID: 8980241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]